NASDAQ:TGTX

Tg Therapeutics Stock Forecast

etoro logo Buy TGTX
*Your capital is at risk
$53.31
-0.210 (-0.392%)
At Close: Jul 02, 2026
AI Analysis AI Analysis of TGTX AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add TGTX to Watchlist?
Some Reasons Why To Add TGTX:
  • High gross margin of 83.0%
  • Strong return on equity of 87.4%
  • +82.1% YTD performance
PDF

TG Therapeutics stock downgraded to Hold/Accumulate
(Updated on Jul 02, 2026)

Buy or Hold candidate since Jun 03, 2026 Gain 32.91%

The TG Therapeutics stock price fell by -0.392% on the last day (Thursday, 2nd Jul 2026) from $53.52 to $53.31. It has now fallen 4 days in a row. During the last trading day the stock fluctuated 5.12% from a day low at $51.15 to a day high of $53.77. The price has fallen in 6 of the last 10 days but is still up by 3.51% over the past 2 weeks. Volume has increased on the last day by 1 million shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 3 million shares were bought and sold for approximately $162.15 million.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 58.51% during the next 3 months and, with a 90% probability hold a price between $69.61 and $90.69 at the end of this 3-month period.

TGTX Signals & Forecast

The TG Therapeutics stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $54.36. On a fall, the stock will find some support from the long-term average at approximately $45.52. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Friday, June 26, 2026, and so far it has fallen -4.51%. Further fall is indicated until a new bottom pivot has been found. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for TG Therapeutics stock

TG Therapeutics finds support from accumulated volume at $53.22 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $2.62 between high and low, or 5.12%. For the last week, the stock has had daily average volatility of 4.36%.

Our recommended stop-loss: $51.18 (-4.00%) (This stock has high daily movements and this gives high risk. There is a sell signal from a pivot top found 4 days ago.)

Trading Expectations (TGTX) For The Upcoming Trading Day Of Monday 6th

For the upcoming trading day on Monday, 6th we expect TG Therapeutics to open at $52.74, and during the day (based on 14 day Average True Range), to move between $52.14 and $54.48, which gives a possible trading interval of +/-$2.34 (+/-4.49%) up or down from last closing price. If TG Therapeutics takes out the full calculated possible swing range there will be an estimated 4.49% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $53.22 (0.17%) than the resistance at $53.94 (1.18%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is TG Therapeutics stock A Buy?

TG Therapeutics holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold candidate.

Current score: 0.322 Hold/Accumulate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on July 6, 2026 - $52.74 ( 1.06%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

TGTX Performance

Trading levels for TGTX

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 55.36 3.85%
R2 54.36 1.97%
R1 53.74 0.81%
Price 53.31
S1 51.74 -2.94%
S2 51.12 -4.10%
S3 50.12 -5.98%

Accumulated Volume Support & Resistance Levels

Level Price
R3 55.83 4.73%
R2 54.40 2.04%
R1 53.94 1.18%
Price 53.31
S1 53.22 -0.169%
S2 46.62 -12.55%
S3 41.97 -21.27%

FAQ

What is the symbol for TG Therapeutics Stock and on which exchange is it traded?
The symbol for TG Therapeutics is TGTX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell TG Therapeutics Stock?
TG Therapeutics holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold candidate.

How to buy TG Therapeutics Stock?
TG Therapeutics Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy TG Therapeutics Stock.

What's the current price of TG Therapeutics Stock?
As of the end of day on the Jul 02, 2026, the price of an TG Therapeutics (TGTX) share was $53.31.

What is the 52-week high and low for TG Therapeutics Stock?
The 52-week high for TG Therapeutics Stock is $57.38 and the 52-week low is $25.28.

What is the market capitalization of TG Therapeutics Stock?
As of the Jul 02, 2026, the market capitalization of TG Therapeutics is 8.161B.

When is the next earnings date for TG Therapeutics?
The upcoming earnings date for TG Therapeutics is Aug 03, 2026.
Click to get the best stock tips daily for free!
ABOUT TG THERAPEUTICS
TG Therapeutics
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hodgkin lymphoma, chronic lymphocytic leukemia (CLL), and relapsing forms of multiple sclerosis; and Umbra...
GOLDEN STAR
Ticker Change Signal Date
B
BXDC
$21.71
1.11% Jun 29
SRPT
$17.02
13.28% Jun 29
OSIS
$218.29
1.59% Jun 26
NMRK
$15.02
4.66% Jun 24
JLL
$299.78
9.23% Jun 24

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE